Delivery Order SPE2DB24D1107-SPE2DB25FZGB3
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,297.40 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Restasis 0.05% eye emulsion (60-unit package). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a $1,293.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,117.68 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (60 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Restasis 0.05% Eye Emulsion in quantities of 30 units, with a firm fixed price ceiling value of $2,716.92. This is a non-set-aside award with an ultimate completion date of August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's extensive...
- This is a $31,894.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of RESTASIS 0.05% eye emulsion. The contract has an ultimate completion date of October 13, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This delivery order is part of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Restasis 0.05% eye emulsion (30 count) at a firm fixed price of $1,117.80. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 4, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Restasis 0.05% eye emulsion. The $3,827.40 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA with a performance period through December...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,262.57 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RESTASIS 0.05% Eye Emulsion, a prescription pharmaceutical product, with a performance period ending on April 24, 2024. This Delivery Order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $9,993.83 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 60 units of Restasis 0.05% eye emulsion. Performance will take place in Conshohocken, Pennsylvania over one day in late June 2023. The Defense Logistics Agency Troop Support Medical supports the medical supply needs of the U.S. Department of Defense. This delivery order was issued...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,820.38 firm fixed-price delivery order is for RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...